A study led by researchers at the Stanford University School of Medicine reports an increased risk of blood clotting at the point where the patient's blood vessels are connected to the dialysis machine known as the point of vascular access.
"Our analysis shows another adverse consequence associated with a fall in blood pressure during dialysis for patients," said Tara Chang, a Stanford nephrologist. "Vascular access is their lifeline. It's required for dialysis and without dialysis, they'll die."
Dialysis is a life-extending procedure that, for most patients with kidney failure, involves sitting in a chair three or more times a week connected to an artificial kidney machine. Blood is cleansed by exchanging fluid and electrolytes across a membrane during each three- to four-hour session. Patients are attached to the dialysis machine through several means.
One of the most common forms of vascular access is a fistula, which is created surgically from the patient's own blood vessels. The tubes used to take blood to and from the body to the dialysis machine are connected to the body at this access point.
Clotting is one of the primary complications of an access point and can lead to its closure.
"These access points don't last forever," said Chang. "Many patients go through multiple access points moving from the right to left arm, or into the legs if necessary after repeated failures in the arms. When a patient runs out of access points, it becomes an emergency situation. Anything you can do to extend the life of the access point is important."
The researchers found that patients who had the most frequent episodes of low blood pressure during dialysis were two times more likely to have a clotted fistula than patients with the fewest episodes.
"Physicians already try to avoid low blood pressure during dialysis through various means," Chang said. "There is so much we don't know about blood pressure in people on dialysis. We need future blood pressure management studies to look at not only mortality and hospitalization, but also consider vascular access survival as another important endpoint to study."
MEDICA.de; Source: The Stanford University School of Medicine